₹19.5

▼ -2 -9.30%

As of 22 Sept 2026 · delayed

NSE Listed

Medistep Healthcare Ltd. (MEDISTEP)

Volume: 6,000Avg Vol 1W: 3,000Avg Vol 1M: 9,75052W Range:₹16.5₹34

NSE BSE www.medistephc.com AI Report

Key Ratios

Checked 5h ago

Market Cap₹28 Cr

Current Price₹19.5

Previous Close₹21.5

High / Low (52w)₹34 / ₹16.5

Volume6,000

Avg Vol (1W)3,000

Avg Vol (1M)9,750

Stock P/E4.63

Book Value₹26.62

Dividend Yield0%

ROE15.82%

ROA0%

Revenue (TTM)₹71 Cr

Revenue Growth—

Profit Margin7.95%

Total Debt—

Shares Outstanding1 Cr

Face Value₹10

EPS (TTM)₹4.21

P/B0.73

Debt / Equity0.11

50 DMA₹20.24

200 DMA₹21.87

Day change-9.30%

Price Chart

₹19.5▼ 40.91% · 1Y

2025-09-22

2026-09-22

20-day avg volume: 10K shares

Pros

Healthy return on equity of 15.8%.
Company is almost debt-free.
Stock trades below its book value.

Cons

Revenue fell 36% YoY.

Quarterly Results

Metric	Jun 2024
Revenue	₹11 Cr
EBITDA	₹1 Cr
Net Profit	₹1 Cr
EPS	—

Profit & Loss (Annual)

Metric	Mar 2024	Mar 2025	Mar 2026
Revenue	₹32 Cr	₹50 Cr	₹71 Cr
EBITDA	₹4 Cr	₹6 Cr	₹8 Cr
Net Profit	₹3 Cr	₹4 Cr	₹6 Cr
EPS	19.96	4.01	4.68

Balance Sheet

Metric	Mar 2024	Mar 2025	Mar 2026
Total Assets	₹15 Cr	₹23 Cr	₹50 Cr
Total Liabilities	₹3 Cr	₹6 Cr	₹12 Cr
Equity	₹12 Cr	₹17 Cr	₹38 Cr
Total Debt	—	—	—

Cash Flow

Metric	Mar 2024	Mar 2025	Mar 2026
Operating	₹-7 Cr	₹0 Cr	₹-18 Cr
Investing	₹0 Cr	₹0 Cr	₹0 Cr
Financing	₹7 Cr	₹1 Cr	₹19 Cr
Free Cash Flow	₹-7 Cr	₹0 Cr	₹-18 Cr

Shareholding

Promoter 68.96% Institutions 0% Public 31.04%

Efficiency & Working Capital

ROCE19.2%

Interest Coverage31.7

Dividend Payout—

Debtor Days203 d

Inventory Days32 d

Payable Days19 d

Cash Conversion Cycle216 d

Working Capital Days235 d

Shareholding Details

As of 2026-03-31

Promoter69%

FII0%

DII0%

Institutions0%

Public31%

Promoter Pledge0%

No. of Shareholders514

Shareholding Pattern

Quarterly — figures in %. Latest 5 quarters.

Period	Dec 2024	Aug 2025	Aug 2025	Sept 2025	Mar 2026
Promoters	93.6%	69%	69%	69%	69%
FIIs	0%	0%	0%	0%	0%
DIIs	0%	0%	0%	0%	0%
Public	6.4%	31%	31%	31%	31%
Promoter Pledge	0%	0%	0%	0%	0%
No. of Shareholders	8	525	525	578	514

Returns History (ROE / ROCE / ROA)

Period	ROE	ROCE	ROA	P/E
202603	—	—	—	—

Major Shareholders (>1%)

Name	Category	Stake	Shares
Prajapati Hetalben Shankarlal	Shareholding of Promoter and Promoter Group	50.1%	71,16,400
Girdharilal Prajapat	Shareholding of Promoter and Promoter Group	9.9%	14,11,800
Vipul Gobarbhai Dabhi	Shareholding of Promoter and Promoter Group	8.9%	12,69,880
Nitin Singh Bhati	Public Shareholding	4.7%	6,66,666
Vijith Narayanan Menon	Public Shareholding	2.6%	3,69,000
Tirulekha Biosciences Private Limited	Public Shareholding	1.9%	2,76,000
Babitha Menon	Public Shareholding	1.8%	2,55,000
Dharmishthaben Vipulbhai Dabhi	Shareholding of Promoter and Promoter Group	0%	200

Board of Directors

Name	Designation	Year
Girdhari Lal Prajapat	Managing Director	2025
Vipul Gobarbhai Dabhi	Executive Director	2025
Hetalben Girdharilal Prajapati	Non Executive Director	2025
Anandbhai Jitendrabhai Khoda	Independent Non Exe. Director	2025
Kapilbhai Raysinhbhai Dodiya	Independent Non Exe. Director	2025
Sashikala Bhutra	Company Sec. & Compli. Officer	2025

Segments — Product

Segment	Revenue	Share
Manufacturing segment	₹13 Cr	26.5%
Trading	₹36 Cr	73.5%

Capital Structure (₹ Cr)

Year	Face Value	Authorised	Issued	Paid-up
2026	₹10	15	14	14

Related-Party Transactions (₹ Cr)

Year	Subsidiaries	Associates	JV	KMP	Others	Total
2026	0	0	0	0	0	0
2026	0	0	0	0	0	0
2026	0	0	0	0	0	0

More stocks

Global Health Limited Medi Assist Healthcare Services Ltd.Medicamen Biotech Medi-Caps Ltd.Medico Remedies Limited Medicamen Organics Ltd.Medplus Health Services Ltd.Meesho Limited Mega Flex Plastics Ltd.Megastar Foods Limited Megatherm Induction Ltd.Mangal Electrical Industries Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search